Last reviewed · How we verify
NCT04578366
Extracorporeal Shockwave Therapy in Long-term Functional Outcomes of Shoulder Adhesive Capsulitis
NA trial testing Extracorporeal Shockwave Therapy in Adhesive Capsulitis of Shoulder in 26 participants. Completed in 28 June 2020.
20 June 2020
Quick facts
| Lead sponsor | Riphah International University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 26 |
| Start date | 15 October 2019 |
| Primary completion | 20 June 2020 |
| Estimated completion | 28 June 2020 |
| Sites | 1 location across Pakistan |
Drugs / interventions tested
- Extracorporeal Shockwave Therapy
- Conventional Treatment — full drug profile →
Conditions studied
- Adhesive Capsulitis of Shoulder — all drugs for Adhesive Capsulitis of Shoulder →
Sponsor
Riphah International University
Who can join
Adults 25 to 65, any sex, with Adhesive Capsulitis of Shoulder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Adhesive capsulitis refers to the occurrence of pain and a gradual decline in the range of motion (ROM) due to slow increases in synovial hypertrophy and the adhesion between the synovial membrane and articular surface. It leads to the loss of flexibility and difficulties with the activities of daily living (ADLs) due to chronic inflammation accompanied by intra-articular fibrosis. The real cause of this syndrome is unknown but there are some predisposing factors involved such as synovial cell hyperplasia, fibrosis of the capsule due to cytokines or other inflammatory factors. In the current study investigator will compare the effects of Extracorporeal Shockwave Therapy (ESWT) along with conventional therapy to treat the adhesive capsulitis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04578366
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Extracorporeal Shockwave Therapy
Trials testing the same drug.
- NCT07483320 — Extracorporeal Shockwave Therapy and Platelet-Rich Plasma for Midportion Achilles Tendinopathy · NA · not yet recruiting
- NCT07317297 — Extracorporeal Shockwave Therapy in the Treatment of Peyronie's Disease · NA · recruiting
- NCT07196267 — Shockwave and Cryoflow for Shoulder Pain After Stroke · NA · completed
- NCT06210399 — Shockwave Therapy in Patients With Chronic Wounds · NA · completed
- NCT06548321 — Benefits of Extracorporeal Shockwave Therapy to Reduce Spasticity in Stroke/CP · NA · active not recruiting
Other recruiting trials for Adhesive Capsulitis of Shoulder
Currently open trials in the same condition.
- NCT06686277 — Effects Of Gong's Versus Mulligan Mobilization In Patients With Adhesive Capsulitis · NA · recruiting
- NCT05384093 — Outcomes of Treatment Using the ERMI Shoulder Flexionater ® · NA · recruiting
Other Riphah International University trials
Trials by the same sponsor.
- NCT07579585 — Effects of Photobiomodulation in Hemophilia Patients. · NA · recruiting
- NCT07504276 — Tele-Rehabilitation vs Conventional Rehabilitation for Cognitive Improvement in Stroke Survivors. · NA · recruiting
- NCT07484477 — Sedentary Behavior Modification, Cardiopulmonary Function & QOL Post Cardiac Surgery Patients. · NA · not yet recruiting
- NCT07438587 — Comparative Effects of Cadence Training vs Elliptical Training in Cricketers · NA · not yet recruiting
- NCT07484399 — Comparing Effects of HIIT and MICT on Functional Mobility, Muscle Strength, and Quality of Life in Diabetic Patients · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04578366 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Riphah International University
- Last refreshed: 8 October 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04578366.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing